Pregledni rad

https://doi.org/10.21860/medflum2017_182975

Treatment of kidney cancer – oncological approach

Dag Zahirović ; Klinika za radioterapiju i onkologiju, KBC Rijeka, Rijeka, Hrvatska
Arnela Redžović ; Klinika za radioterapiju i onkologiju, KBC Rijeka, Rijeka, Hrvatska
Marija Petković ; Klinika za radioterapiju i onkologiju, KBC Rijeka, Rijeka, Hrvatska
Ingrid Belac Lovasić ; Klinika za radioterapiju i onkologiju, KBC Rijeka, Rijeka, Hrvatska

Sažetak

Improvement in knowledge of molecular pathways of growth and developement of malignant kidney cancer has led to development of a number of efficient drugs. In this way the treatment of this condition nowadays is possible and successfull as documented by many clinical trials. New ways of treating kidney cancer tend to fulfill primary oncology goals which are to cure completely the patient or to make this serious disease a longlasting chronic disease.

Ključne riječi

angiogenesis factor inhibitors; antineoplastic agents; kidney cancer; monoclonal antibodies

Hrčak ID:

184846

URI

https://hrcak.srce.hr/184846

Datum izdavanja:

1.9.2017.

Podaci na drugim jezicima: hrvatski

Posjeta: 7.873 *